Citius Oncology (CTOR) Other Non-Current Liabilities (2024 - 2026)

Citius Oncology's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $559015.0 for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $559015.0; the TTM figure through Mar 2026 stood at $559015.0 (changed 0.0% YoY), while the FY2025 annual figure was $559015.0, changed N/A from the prior year.
• Other Non-Current Liabilities was $559015.0 for Q1 2026 at Citius Oncology, roughly flat from $559015.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $559015.0 in Q4 2024 to a low of $559015.0 in Q4 2024.
• Historically, Other Non-Current Liabilities has averaged $559015.0 across 3 years, with a median of $559015.0 in 2024.
• Biggest YoY gain for Other Non-Current Liabilities was 0.0% in 2025; the steepest drop was 0.0% in 2025.
• A 3-year view of Other Non-Current Liabilities shows it stood at $559015.0 in 2024, then changed by 0.0% to $559015.0 in 2025, then changed by 0.0% to $559015.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $559015.0 (Q1 2026), $559015.0 (Q4 2025), and $559015.0 (Q3 2025), per Business Quant data.